◆ 会议时间：2025年5月18-20日
◆ 会议地点：土耳其 伊斯坦布尔

◆ 会议简介：

2025年第16届国际欧亚血液肿瘤学大会(EHOC)将于2025年5月18-20日在土耳其伊斯坦布尔举行，会议由欧亚血液肿瘤学工作组(EHOG)主办。EHOC是土耳其和其他地区从事血液学的科学、医疗、实践、技术、行政和教育方面的临床医生和科学家的非营利组织；通过提供教育和培训宣机会，EHOC有助于改善患有血液疾病的患者的健康状况。未经许可禁止复制摘录转载本站任何内容-领域国际医学会议网(lingyuint.com)

16th Eurasian Hematology Oncology Congress (EHOC 2025)

Date:
May 18-20, 2025

Venue:
Hilton Istanbul Maslak, Istanbul, Turkey

Organized by:
Eurasian Hematology Oncology Group (EHOG)
Hematology Specialty Association (HSA)

摘要征文投稿：

Abstract Submission Deadline : March 7, 2025 / 23:59 (local time)

点此提交摘要>>>Submit Abstract>>>

GUIDELINES

• Objective, Methodology, Results and Conclusion parts can be maximum 350 words. If your abstract is a Case Report, please enter the entire text body into the Case Report box. Case Reports can not exceed 350 words.

• The names and surnames of the authors should be fully spelled out and the name of person that will present the presentation should be selected. The surnames of the authors should be written in uppercase.

• The presenting author is required to ensure that all co-authors are aware of the content of the abstract before submission.

• The presenting author must be listed as the first author.

• All abstracts should be submitted and presented in clear English with accurate grammar and spelling of a quality suitable for publication. If you need help, please arrange for the review of your abstract by a colleague who is a native English speaker, by a university specific publications office (or other similar facility) or by a copy editor, prior to submission.

• All abstracts accepted for presentation will be published on the Conference website prior to the Congress.

• Please note the submitting author will receive all correspondence about the abstract so we advise that the submitting author details that are entered are the same details as those of the presenting author.

• Abstracts may not be edited/updated after final submission.

• Your abstract is not successfully submitted until you receive a confirmation e-mail after clicking the final submit button. If you do not receive a confirmation e-mail, please contact us.

• Abstracts can only be submitted via the online abstract submission form. We kindly request you to fill in the necessary information in the form with the following guidelines

• You may enter up to 15 authors in the authors list including the Presenter.

AUTHOR’S DECLARATION

• I confirm that I previewed this abstract and that all the information is correct. I accept that the content of this abstract cannot be modified or corrected after final submission and I am aware that it will be published as submitted.

• Submission of the abstract constitutes the consent of all authors to publication (e.g. Conference website, programs, other promotions, etc.)

• The Abstract Submitter warrants and represents that no part of the information and content provided by him/her infringes any third party rights, including but not limited to privacy rights and/or intellectual property rights.

• I herewith confirm that the contact details saved in this system are those of the presenting author, who will be notified about the status of the abstract. The presenting author is responsible for informing the other authors about the status of the abstract.

• I understand that the presenting author must be a registered participant.

• The Organizers reserve the right to remove from publication and/or presentation an abstract that does not comply with the above.

• I understand that I must select a specific Abstract Category and Topic for my abstract allocation. Although the committee will work hard to honor this selection, this cannot be guaranteed. The Committee reserves the right to change the Category or Topic under which the abstract was originally submitted.

Dear Colleagues,

The Hematology Specialty Association (HSA) is an organization founded by hematology specialists in Turkiye. Our association/provides opportunities for hematologists to enhance their knowledge and experience while also engaging in public welfare activities to educate the public about hematology.

One of our association's fundamental aims is to create platforms for collaboration with other countries to establish mutual information and scientific exchange and become a hematology hub in the region to facilitate international events. To achieve this goal, HSA formed an international scientific board called the Eurasian Hematology Oncology Group (EHOG) in 2017 to organize these events.

We are pleased to announce that the 16th edition of the Eurasian Hematology Oncology Congress (EHOC 2025) will take place at Hilton Istanbul Maslak from May 18th to 20th.

We believe deep in our hearts that EHOC 2025 will fill a significant gap in our region with its special concept.

Abstracts that have been submitted to EHOC 2022 will be evaluated by an international reviewing committee, and accepted abstracts will be presented in the oral and poster presentation sessions of EHOC 2025, and they will be published online as a supplement to the Journal of Hematology, Transfusion and Cell Therapy published by Elsevier.

Pharmaceutical companies will get an opportunity to interact with the attendees in the exhibition area.

We hope you will benefit in the best way possible from EHOC 2025.

See you in İstanbul

Eurasian Hematology Oncology Group

注册费：

REGISTRATION FEES

General Rules

Registration fee; It includes the participation of a single person who physically attends the meetings.

Registration fees do not include VAT (20%).

◆ 参会对象：医生、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。